Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cui Cai

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi = Chinese Journal of Schistosomiasis Control|January 30, 2018
[Effect of two-level community-based health education pattern on schistosomiasis control]Zhang Xia, Hu He-Hua, Liu Xiong, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 4, 2009
Mitochondrial genome evidence reveals successful Late Paleolithic settlement on the Tibetan PlateauMian Zhao, Qing-Peng Kong, Hua-Wei Wang, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|April 3, 2026
QT Interval Prolongation and Cardiotoxicity in Shorter Regimens for Rifampicin Resistant TuberculosisYilin Zhang, Yang Li, Yuanyuan Chen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 8, 2025
A Short, All-Oral Regimen for Pre-Extensively Drug-Resistant Tuberculosis: A Multicenter Open-label Single-arm StudyYang Li, Yilin Zhang, Lingyun Song, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|November 6, 2025
Acquired resistance during short-course treatment for rifampicin-resistant tuberculosisXinchang Chen, Cui Cai, Lingyun Song, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|November 26, 2025
A 6- to 9-months oral regimen for rifampicin-resistant tuberculosis: a randomized open-label noninferiority trial in ChinaFeng Sun, Yang Li, Yilin Zhang, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|January 9, 2021
Patient pathway analysis of tuberculosis diagnostic delay: a multicentre retrospective cohort study in ChinaLu Zhang, Tao-Ping Weng, Hong-Yu Wang, et al.
Infectious Diseases of Poverty|March 19, 2021
Bedaquiline-containing regimens in patients with pulmonary multidrug-resistant tuberculosis in China: focus on the safetyJing-Tao Gao, Juan Du, Gui-Hui Wu, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi = Chinese Journal of Schistosomiasis Control|January 30, 2018
[Effect of two-level community-based health education pattern on schistosomiasis control]Zhang Xia, Hu He-Hua, Liu Xiong, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 4, 2009
Mitochondrial genome evidence reveals successful Late Paleolithic settlement on the Tibetan PlateauMian Zhao, Qing-Peng Kong, Hua-Wei Wang, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|April 3, 2026
QT Interval Prolongation and Cardiotoxicity in Shorter Regimens for Rifampicin Resistant TuberculosisYilin Zhang, Yang Li, Yuanyuan Chen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 8, 2025
A Short, All-Oral Regimen for Pre-Extensively Drug-Resistant Tuberculosis: A Multicenter Open-label Single-arm StudyYang Li, Yilin Zhang, Lingyun Song, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|November 6, 2025
Acquired resistance during short-course treatment for rifampicin-resistant tuberculosisXinchang Chen, Cui Cai, Lingyun Song, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|November 26, 2025
A 6- to 9-months oral regimen for rifampicin-resistant tuberculosis: a randomized open-label noninferiority trial in ChinaFeng Sun, Yang Li, Yilin Zhang, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|January 9, 2021
Patient pathway analysis of tuberculosis diagnostic delay: a multicentre retrospective cohort study in ChinaLu Zhang, Tao-Ping Weng, Hong-Yu Wang, et al.
Infectious Diseases of Poverty|March 19, 2021
Bedaquiline-containing regimens in patients with pulmonary multidrug-resistant tuberculosis in China: focus on the safetyJing-Tao Gao, Juan Du, Gui-Hui Wu, et al.
Pageof 3